Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
Adaptimmune (ADAP) Gains on Deal With Roche for Cell Therapies
12:30pm, Wednesday, 08'th Sep 2021
Adaptimmune (ADAP) shares jump on a collaboration and license agreement with Roche for the development of allogeneic T-cell therapies for up to five shared cancer targets.
Roche to present data from industry leading portfolio at ESMO 2021 showing significant progress in early stage and uncommon cancers
01:00am, Tuesday, 07'th Sep 2021
Basel, 07 September 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new oncology data will be presented at the European Society for Medical Oncology (ESMO) Congress, which will be held
STATE COLLEGE, Pa. and PHILADELPHIA, Sept.
Else Nutrition expands its Plant-Based Complete Nutrition for Toddlers into Roche Bros. locations this September
07:42am, Wednesday, 01'st Sep 2021
Else Nutrition Holdings Inc.. has said it will be expanding into Roche Bros.
Roche Partners with the Kolisi Foundation, One By One Target Covid Campaign and Transnet to Launch Free COVID-19 Children's Book
05:23pm, Monday, 30'th Aug 2021
JOHANNESBURG--(BUSINESS WIRE)--Roche and the Kolisi Foundation today launched a children's book, Keto and Zuri Learn about COVID-19, that will help parents and caregivers across Africa explain COVID-1
Roche (RHHBY) Withdraws Tecentriq for Breast Cancer in the U.S.
12:56pm, Monday, 30'th Aug 2021
Roche (RHHBY) will withdraw Tecentriq for treating adults with unresectable locally advanced or metastatic triple-negative breast cancer in the United States.
After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US
02:02pm, Friday, 27'th Aug 2021
Following a consultation from the FDA, Roche Holdings AG (OTC: RHHBY) has decided to withdraw its immunotherapy, Tecentriq (atezolizumab), to treat a type of breast cancer in the U.S. Earlier this
Tonight! Novartis, Roche, BeiGene, Others Discuss Global Fight Against Cancer In Covid Era
11:46am, Friday, 27'th Aug 2021
Against that backdrop, Forbes China will hold the second “Forbes China Healthcare Summit” at 8pm ET tonight (8am on August 28 in China).
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer
11:45am, Friday, 27'th Aug 2021
Basel, 27 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in
Which Biotech Stock Will Shock the Market in 2022?
10:40am, Friday, 27'th Aug 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Seattle biotech firm Shape Therapeutics inks gene therapy deal with Roche worth up to $3B
01:06pm, Tuesday, 24'th Aug 2021
Shape Therapeutics has signed a deal potentially exceeding $3 billion with pharma giant Roche to support the development of gene therapies for Alzheimer's and Parkinson's disease, the Seattle company
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
11:41am, Tuesday, 24'th Aug 2021
Shape Therapeutics Inc announced a multi-target strategic collaboration and license agreement with Roche Holding AG (OTC: RHHBY) for RNA editing technology. Through this partnership, ShapeTX wil
Cathie Wood's ARK Invest Sells Over 175,000 Shares of Roche
09:48am, Friday, 20'th Aug 2021
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 175,000 shares of Roche Holding AG (NYSEARCA: RHHBY) on Thursday, as the share price of this fund traded down nearly 2% in the
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
09:47am, Friday, 20'th Aug 2021
The U.K. drug regulator has approved an antibody cocktail developed by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Roche Holding AG (OTC: RHHBY) to prevent and treat COVID-19. The U.K. chief m
Analog Devices, Inc. (ADI) CEO Vince Roche on Q3 2021 Results - Earnings Call Transcript
01:05pm, Wednesday, 18'th Aug 2021
Analog Devices, Inc. (ADI) CEO Vince Roche on Q3 2021 Results - Earnings Call Transcript
